MODD
Modular Medical, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$3.68
+7.60%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−1.0x
Market Cap
$30.00M
MomentumView details →
1D Return
+7.60%
YTD Return
−66.30%
RSI (14)
58.4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−1.0x
Market Cap
$30.00M
RSI (14)
58.4
MomentumView details →
1D Return
+7.60%
YTD Return
−66.30%
SummaryUpdated Jun 1, 2026
Modular Medical, Inc. (NASDAQ:MODD) is a development-stage medical device company founded to revolutionize diabetes management through innovative insulin pump technology. The company went public in February 2022 and is headquartered in San Diego, California. Since its IPO, Modular Medical has been focused on developing and commercializing next-generation insulin delivery systems designed to improve adoption rates among diabetic patients who require insulin therapy.
Similar companies
Latest newsMore news →
Modular Medical announced it secured a contract with a national U.S. pharmacy benefit manager, making its Pivot insulin delivery system available through the PBM.10h agoModular Medical, Inc. announced on Thursday that the U.S. Food & Drug Administration cleared software enhancements to its Pivot insulin delivery system.1d agoModular Medical announced the launch of its Pivot Insulin Delivery System across five key U.S. markets beginning October 2026, with Inizio providing commercialization expertise.32d ago